bioLytical Laboratories Inc - Product Pipeline Analysis, 2018 Update

bioLytical Laboratories Inc - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME15380PD
  • |
  • Pages: 27
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

bioLytical Laboratories Inc (bioLytical) is a medical device company that develops and manufactures HIV diagnostic products. The company provides products such as insti HIV-1 and HIV-2 antibody test and insti HIV-1 and HIV-2 test controls. Its product line offers test result that translates into a value proposition. bioLytical provides insti kit which is a rapid antibody test, that detects antibodies of human immunodeficiency virus type one and type two in human whole blood, fingerstick blood, serum and plasma, among others. The company caters tests for diseases such as hepatitis C, Ebola, R and D programs, patients, healthcare professionals, payers, public health organizations, and others. It provides customer care services and markets its products through distributors in Canada and India. bioLytical is headquartered in Richmond, British Columbia, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company bioLytical Laboratories Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

bioLytical Laboratories Inc Company Overview 4

bioLytical Laboratories Inc Company Snapshot 4

bioLytical Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview 4

bioLytical Laboratories Inc-Pipeline Analysis Overview 6

bioLytical Laboratories Inc-Key Facts 6

bioLytical Laboratories Inc-Major Products and Services 7

bioLytical Laboratories Inc Pipeline Products by Development Stage 8

bioLytical Laboratories Inc Pipeline Products Overview 10

INSTI Ebola Test 10

INSTI Ebola Test Product Overview 10

INSTI Test-Chikungunya 11

INSTI Test-Chikungunya Product Overview 11

INSTI Test-Dengue 12

INSTI Test-Dengue Product Overview 12

INSTI Test-Hepatitis B 13

INSTI Test-Hepatitis B Product Overview 13

INSTI Test-Hepatitis C 14

INSTI Test-Hepatitis C Product Overview 14

Zika/Flavivirus Test 15

Zika/Flavivirus Test Product Overview 15

bioLytical Laboratories Inc-Key Competitors 16

bioLytical Laboratories Inc-Key Employees 17

bioLytical Laboratories Inc-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

bioLytical Laboratories Inc, Recent Developments 19

Nov 24, 2017: VANC Pharmaceuticals Plans to Launch INSTI HIV Test with United Pharma Group on World AIDS Day 19

Jul 28, 2017: INSTI HIV Self Test detects HIV two weeks sooner than other brands 19

Jul 28, 2017: Instant HIV home test launched in the Netherlands 20

Jul 27, 2017: INSTI HIV Self Test Demonstrates High User Acceptance in Kenya Study 20

Jul 06, 2017: INSTI HIV Self Test Receives Global Fund Classification for Procurement 20

May 17, 2017: VANC Pharmaceuticals Announces Canadian Distribution Agreement for INSTI HIV-1/HIV-2 Antibody Test 21

Apr 24, 2017: Instant HIV Home Test Launched in Belgium 22

Feb 21, 2017: BioLytical Receives Innovative Technology Contract from Vizient for Rapid HIV Test 22

Dec 02, 2016: bioLytical Introduces INSTI HIV Self Test to Kenyan Regulated Pharmacy Network 22

Dec 01, 2016: bioLytical Launches INSTI HIV Self Test for African Market in Response to New WHO Guidelines 23

Appendix 24

Methodology 24

About GlobalData 26

Contact Us 26

Disclaimer 27

List of Figures

bioLytical Laboratories Inc Pipeline Products by Equipment Type 5

bioLytical Laboratories Inc Pipeline Products by Development Stage 8

List of Tables

bioLytical Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview 4

bioLytical Laboratories Inc Pipeline Products by Equipment Type 5

bioLytical Laboratories Inc Pipeline Products by Indication 5

bioLytical Laboratories Inc, Key Facts 6

bioLytical Laboratories Inc, Major Products and Services 7

bioLytical Laboratories Inc Number of Pipeline Products by Development Stage 8

bioLytical Laboratories Inc Pipeline Products Summary by Development Stage 9

INSTI Ebola Test-Product Status 10

INSTI Ebola Test-Product Description 10

INSTI Test-Chikungunya-Product Status 11

INSTI Test-Chikungunya-Product Description 11

INSTI Test-Dengue-Product Status 12

INSTI Test-Dengue-Product Description 12

INSTI Test-Hepatitis B-Product Status 13

INSTI Test-Hepatitis B-Product Description 13

INSTI Test-Hepatitis C-Product Status 14

INSTI Test-Hepatitis C-Product Description 14

Zika/Flavivirus Test-Product Status 15

Zika/Flavivirus Test-Product Description 15

bioLytical Laboratories Inc, Key Employees 17

bioLytical Laboratories Inc, Other Locations 18

Glossary 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Qualyst Transporter Solutions LLC

Maxim Biomedical Inc

Home Health Care Management Inc

Amplyx Pharmaceuticals Inc

Amico Corp

Alethia Biotherapeutics Inc

Affinity Biologicals Inc

Abt Associates Inc

bioLytical Laboratories Inc,Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53520
Site License
USD 1500 INR 107040
Corporate User License
USD 2250 INR 160560

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com